Post-approval studies (Phase 4)Study completedNCT03503188What this trial is testingDigital Auscultation Test - IPF Data CollectionWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 274
Early research (Phase 1)Looking for participantsNCT03535545What this trial is testingPreliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsWho this might be right forPulmonary FibrosisLung Cancer Massachusetts General Hospital 100
Early research (Phase 1)Ended earlyNCT02013700What this trial is testingAllogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER)Who this might be right forIdiopathic Pulmonary Fibrosis (IPF) Joshua M Hare 9
Early research (Phase 1)Study completedNCT06230822What this trial is testingSafety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Wuhan Optics Valley Vcanbiopharma Co., Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05828953What this trial is testingAnlotinib Capsules in the Treatment for IPF/PF-ILDsWho this might be right forInterstitial Lung Diseases First Affiliated Hospital of Wenzhou Medical University 30
Not applicableStudy completedNCT07031362What this trial is testingThe Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIPFPulmonary Fibrosis Izmir Katip Celebi University 50
Testing effectiveness (Phase 2)Study completedNCT01417156What this trial is testingSafety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)Who this might be right forPulmonary Fibrosis Boehringer Ingelheim 20
Not applicableActive Not RecruitingNCT02755441What this trial is testingPulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPFWho this might be right forIdiopathic Pulmonary Fibrosis Nils Hoyer 450
Not applicableStudy completedNCT04525547What this trial is testingSafety and Effectiveness of Nintedanib in Korean PatientsWho this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 70
Not applicableUnknownNCT05087017What this trial is testingInfluence of Regular Physical Activity on Sleep in Patients With COPD and Idiopathic Lung FibrosisWho this might be right forPulmonary Disease, Chronic ObstructiveFibrosis, Pulmonary Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150
Post-approval studies (Phase 4)WithdrawnNCT00625079What this trial is testingPulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWho this might be right forPulmonary Arterial HypertensionIdiopathic Pulmonary FibrosisInterstitial Lung Disease+1 more University of California, Los Angeles
Post-approval studies (Phase 4)UnknownNCT01382368What this trial is testingAcute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy PatientsWho this might be right forChronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary Fibrosis Rabin Medical Center 60
Not applicableLooking for participantsNCT03800017What this trial is testingSkeletal Muscle Function in Interstitial Lung DiseaseWho this might be right forInterstitial Lung DiseaseIdiopathic Pulmonary FibrosisHypersensitivity Pneumonitis+2 more University of British Columbia 40
Not applicableStudy completedNCT03711435What this trial is testingTraditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and MetabolomicsWho this might be right forIdiopathic Pulmonary Fibrosis Xuzhou Traditional Chinese Medicine Hospital 75
Testing effectiveness (Phase 2)Looking for participantsNCT06968845What this trial is testingLTI-03 in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis (IPF) Rein Therapeutics 120
Early research (Phase 1)Ended earlyNCT03949530What this trial is testingSafety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary FibrosisWho this might be right forHealthy VolunteersIdiopathic Pulmonary Fibrosis Indalo Therapeutics, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT02503657What this trial is testingSafety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary FibrosisIPF MediciNova 15
Testing effectiveness (Phase 2)Study completedNCT05483907What this trial is testingTo Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPFWho this might be right forIdiopathic Pulmonary Fibrosis Bridge Biotherapeutics, Inc. 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT04598919What this trial is testingSaracatinib in the Treatment of Idiopathic Pulmonary FibrosisWho this might be right forIdiopathic Pulmonary Fibrosis (IPF) National Jewish Health 49
Not applicableStudy completedNCT04257630What this trial is testingCoping Strategies Within Pulmonary Rehabilitation in Patients With IPF and COPDWho this might be right forIdiopathic Pulmonary FibrosisChronic Obstructive Pulmonary Disease Schön Klinik Berchtesgadener Land 180